Ixempra (Ixapebilone) – New Cancer Therapy

 

Key Data:

Drug (Brand/Generic)
Ixempra/Ixabepilone
Company/Licensee
BMS
Therapy Class
Epothilone
Product Description
Microtubule inhibitor
Current Indication
Metastatic or locally advanced breast cancer
Market Sector
Oncology
Development Status
Approved in the US

Return to Ixempra (Ixapebilone) – New Cancer Therapy Project



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development